Pierre Lescuyer

Experimental evidence of obesity as a risk factor for severe acute pancreatitis.

Proteomics in clinical chemistry: will it be long?

Analysis of the pancreatic low molecular weight proteome in an animal model of acute pancreatitis.

Comparison of gel-based methods for the detection of cerebrospinal fluid rhinorrhea.

Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.

Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.

An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.

Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.

Assessment of the influence of the patient's inflammatory state on the accuracy of a haptoglobin selected reaction monitoring assay.

Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.

A Population-Based Model to Consider the Effect of Seasonal Variation on Serum 25(OH)D and Vitamin D Status.

Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism.

Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages.

Detection of busulfan adducts on proteins.

Metabolomic analysis of urine samples by UHPLC-QTOF-MS: Impact of normalization strategies.

Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.

IL8 and EDEM3 gene expression ratio indicates peripheral blood mononuclear cell (PBMC) quality.

Detection of Proteoforms Using Top-Down Mass Spectrometry and Diagnostic Ions.

Development of a Highly Multiplexed SRM Assay for Biomarker Discovery in Formalin-Fixed Paraffin-Embedded Tissues.

Toward a better understanding of chronic kidney disease with complementary chromatographic methods hyphenated with mass spectrometry for improved polar metabolome coverage.

Liquid chromatography-high resolution mass spectrometry for broad-spectrum drug screening of dried blood spot as microsampling procedure.

Detection of Unknown Chemical Adduct Modifications on Proteins: From Wet to Dry Laboratory.

Ultrahigh Performance Mass Spectrometry in Clinical Chemistry: A Taste of the Future?